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Breast Density Assessment in Young Women with
Ultrasound based on Speed of Sound: Inﬂuence of
the Menstrual Cycle
Lisa Ruby, MDa,
∗
, Sergio J. Sanabria, PhDa,b, Anika S. Obrist, BMeda, Katharina Martini, MDa,
Seraﬁno Forte, MDc, Orcun Goksel, PhDb, Thomas Frauenfelder, MDa, Rahel A. Kubik-Huch, MDc,
Marga B. Rominger, MDa
Abstract
To investigate changes in breast density (BD) during themenstrual cycle in youngwomen in comparison to inter-breast and -segment
changes as well as reproducibility of a novel Speed-of-Sound (SoS) Ultrasound (US) method.
SoS-US uses a conventional US system with a reﬂector and a software add-on to quantify SoS in the retro-mammillary, inner and
outer segments of both breasts. Twenty healthy women (18–40 years) with regular menstrual cycles were scanned twice with two
weeks in-between. Three of these were additionally measured twice per week for 25 days. Average SoS (m/s) and DSoS (segment-
variation SoS; m/s) were measured. Variations between follicular and luteal phases and changes over the four-week period were
assessed. Inter-examiner and inter-reader agreements were also evaluated. Variances between cycle phases, examiners and
readers were compared.
No signiﬁcant SoS difference was observed between follicular and luteal phases for the twenty women (P= .126), and between all
different days for the three more frequently measured women (P= .892). Inter-reader (ICC=0.999) and inter-examiner (ICC=0.990)
agreements were high. The SoS variance due to menstrual variations was not signiﬁcantly larger than the inter-examiner uncertainty
(P= .461). Inter-reader variations were signiﬁcantly smaller than menstrual and examiner variations (P< .001).
SoS-US showed high inter-examiner and inter-reader reproducibility. The alterations during the menstrual cycles were not
signiﬁcantly larger than the conﬁdence interval of measurements.
Abbreviations: ACR = American College of Radiology, BD = breast density, CI = conﬁdence interval, ICC = intraclass correlation
coefﬁcient, MRI =magnetic resonance imaging, RF = radiofrequency, SoS = speed of sound, US = ultrasound, USCT = ultrasound
computed tomography.
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1. Introduction
Breast density is an important independent risk factor for breast
cancer and increases the accuracy of breast cancer risk models.[1,2]
Several states in the United States have passed legislation, which
requires radiologists to communicate with their patients about
their breast density and discuss supplemental screening methods,
such as sonography or magnetic resonance imaging (MRI).[3] The
12 to 18 month change in breast density has been shown to be a
predictor of response to tamoxifen therapy[4] and variations of
breast density have been observed for women undergoing
controlled ovarian stimulation.[5] Breast density is presently
calculated as a by-product at the time of the ﬁrst mammography,
which currently varies between 40 and 50 years old, depending on
country and recommendation source.[6–8]
Ultrasound (US) is a radiation-free, non-invasive and cost
effective imaging modality. Breast density correlates with the
speed of longitudinal ultrasoundwaves, also known as the Speed-
of-Sound (SoS).[9,10] SoS is a quantitative biomarker measured in
a continuous scale, which would as well be potentially adequate
to non-invasively monitor SoS changes during the menstruation
cycle and as a result of hormonal treatment or medication.
Current SoS measurement systems are based on 3D-US-
tomography, which require a special table or a water bath,
and are associated with long measurement times.[11] While
the complexity of these systems can be justiﬁed for screening of
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early-stage cancers, more simple methods are necessary for the
monitoring of breast density.
Recently, a novel US method, 2D Speed-of-Sound Ultrasound
(SoS-US), hasbeenproposed tomeasurebreast density,which canbe
implemented as an add-on to standard ultrasound systems.[12,13]
This method uses a passive reﬂector opposite to the breast at a
known distance to measure the echo arrival time between a
conventionalUSprobe and said reﬂector.This provides a SoSproﬁle
(m/s) along the probe width. Breast density classiﬁcation based on
SoS-US has demonstrated a strong correlation to ACR density
categories.[12,13] In contrast to 3D-US-tomography, the reﬂector
technique can be quickly performed without a water bath. A
modality like SoS-US would also be adequate to non-invasively
monitor SoS changes during themenstruation cycle and as a result of
hormonal treatment or medication.
With SoS values ranging (5–95% percentile) from 1403m/s for
ACRa(almost entirely fatty) to1506m/s forACRd(extremelydense)
categories,[12,14,15] a SoS range of approximately 100m/s can be
roughly approximated for density variations between 0 and 100%
resulting in a variation of 1m/s per % breast density variation[10],
assuming a linear relationship between both modalities.[16]
The goal of this study was to investigate the inﬂuence of the
menstrual cycle on breast density assessment using SoS-US in
young, healthy women. To our knowledge, this is the ﬁrst pilot
study monitoring the breast density variations of a healthy
population within the same menstrual cycle.
2. Materials and methods
2.1. Study design
This prospective single-institution study was approved by the
institutional review board and local ethics committee “Kant-
onale Ethikkommission Zürich”. The study was performed in
March and April 2018. Twenty healthy volunteers were
selected after a local advertisement. Informed written consent
was obtained from all women. Inclusion criterion was a
regular menstrual cycle, deﬁned as 28+/ 7 days, reported by
the women. The mean age of the women was 26.6 years (range
18–40 years). Volunteers’ characteristics are listed in Table 1.
Exclusion criteria were a previous breast tumor, trauma or
previous biopsies/operations in either breast. None of
the healthy volunteers had undergone mammography. The
women were examined at two time points with a 14-day period
in-between by examiner 1, a ﬁrst-year radiology resident
(L.R.). A menstrual cycle history questionnaire, including the
ﬁrst bleeding day of the last three menstruation cycles, was
completed by the volunteers in a questionnaire and each
participant was allocated to either the follicular (day 1–14) or
luteal (day 15–18) group at each of the twomeasurements days.
The ﬁrst menstruation daymarked the ﬁrst day of themenstrual
cycle. For cycles not lasting 28 days, we assumed a constant
duration of the luteal phase length of 13 to 14 days and a lesser
extent of variation in length than the follicular phase[17–19] to
allocate the women to the correct menstrual phase. On the day
of the second measurement, 18 volunteers (108 breast
segments) were additionally examined by a second examiner,
a third year medical student (A.S.O.), to obtain inter-examiner
agreement. Examiners were blinded to each other’s assessment.
A subgroup of three volunteers (“frequently measured”) were
additionally examined twice a week for a period of 25 days by
examiner 1 (L.R.). 9/20 and 2/3 volunteers reported hormone
contraceptive intake, including oral contraceptives or a
hormone intrauterine device.
2.2. Speed-of-Sound (SoS) Ultrasound (US)
For SoS measurements, we acquired US raw data, also called
radiofrequency (RF) lines, with an aperture of one element with a
commercial US system (SonixTouch, Ultrasonix, Richmond,
Canada). The measurements were performed with a linear
ultrasound array (L14/5–38) with an effective center imaging
frequency of 5MHz. A ﬂat Plexiglas reﬂector located opposite to
the breast was delineated in the acquired ultrasound data and used
as a timing reference for the US signals transmitted through the
breast. Both probe and reﬂector were attached to a frame, which
enabled controlling the distance d (in millimeters) between both
elements (Fig. 1a). Ultrasound lotion (PolySonic, Parker Labora-
tories, Inc., Fairﬁeld, NJ) was applied on the reﬂector and probe
surfaces. The distance d was adjusted to achieve contact between
the US probe, the breast and the reﬂector, read from a digital
distance sensor andused to convert the timeofﬂight of the reﬂector
echo into SoS units. Given a reﬂector echo time t (in seconds), the
SoS (inm/s) is calculatedasSoS=2∗d/t.ASoS segment is calculated
at a deﬁned measurement position by converting the time
coordinate in the RF lines to SoS units according to d.
2.3. Examination protocol
We measured three different (retro-mamillary, outer, inner)
segments in each breast. The “retro-mammillary segment” was
located in the coronal plane two ﬁngerbreadths dorsal of the
mamilla (Fig. 1b). The reﬂector was placed above the breast,
whereas the US probe was located below the breast. Reﬂector and
probe were then rotated 45° around the probe axis and moved to
the outer and inner breast thirds, respectively. The corner of the
reﬂector in the retro-mammillary measurement deﬁned the start
position for the outer and innermeasurements, respectively. In case
of a small breast, the end position of outer and innermeasurements
was given by the chest wall. All study participants sat on a chair in
an upright position during the entire examination.
2.4. Comfort level assessment
We used the Likert scale for assessing the volunteers’ comfort
during the examination. The scale ranged from 1 = “comfortable/
Table 1
Participant data.
Participant data Mean or Median
Age 25.5 years (range 18–40)
Body mass index 23.36±3.61 kg/m2
Height 168.75±4,56 cm
Weight 66.7±11.64 kg
Hormone intake (OC, IUD) YES 9/20 (45%)
BH Cup A (20%), B (25%), C (30%), D (15%), E (10%)
“Probe-reﬂector distance values” 43±7.95 mm
Mean menstrual cycle length 28 days (range 21 – 37)
Menarche age 12 years (range 10–15)
Parity YES 2/20 (10%)
Comfort score (1–5;
1= comfortable/agreeable;
5 = very uncomfortable
and I would never to it again.)
1 (95%), 2 (5%), 3 (0%), 4 (0%), 5 (0%)
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agreeable”, 2 = “slightly uncomfortable but I would do it again”,
3 = “uncomfortable and unsure whether I would do it again”,
4= “quite uncomfortable and Iwould prefer not to do it again”, to
5 = “very uncomfortable and I would never to it again”.
2.5. Reading process
Two blinded human readers (manual reader), one ultrasound
physicist (S.J.S.) and one third-year medical student (A.S.O.),
read the SoS values of all acquired examinations. After a 15-
minute practice, each manual reader independently drew a line
for each measured segment between the minimum and maximum
SoS values in m/s. Then, the average SoS reading (segment-
average) was obtained as the midpoint of both values, and the
DSoS (segment-variation of SoS, “heterogeneity”) was calculated
as the difference of maximum and minimum values (Fig. 1c).
Additionally, an automatic algorithm was used for automatic
reading of SoS and DSoS (automatic reader). The algorithm is
based on the dynamic programming approach of,[13] where a new
algorithm was written at Zurich Ultrasound Research &
Translation (ZURT) to simultaneously account for skin, reﬂector
surface and backwall echoes. It provided the maximum and
minimum values, from which SoS and DSoS were calculated.
Inter-reader agreements between themanual readers and between
the mean of the manual readers and the automatic reader was
assessed for the SoS and DSoS values.
2.6. Statistical analysis
Statistical analysis was performed using SPSS (Statistics software
version 25, IBM, Armonk, NY) and Matlab (R2016b, The
MathWorks Inc., Natick, MA). The means of the six segments of
each woman were used for the investigation of differences
between luteal and follicular phase, inter-examiner and inter-
reader agreement. Statistical differences in SoS and DSoS among
the subjects were assessed using both unpaired and paired t-tests.
Spearman rank correlation coefﬁcients rs and intraclass correla-
tion coefﬁcients (ICC) were calculated to assess correlations of
SoS and DSoS between phases, examiners, and readers.[20,21] The
Bland-Altman method[22] was used to summarize the differences
of SoS and DSoS. Using the calculated mean and the standard
deviation (SD), we calculated the conﬁdence interval (CI) for the
SoS variation between menstrual phases and examiners given the
current sample size.[23] Differences in variance between paired
measurements annotated by different readers, performed by
different examiners, and performed on different days were
assessed using a 2-sample F-test. To avoid clustering data, when
comparing inter-examiner and menstruation cycle variations,
only data from one reader and from one examiner, respectively,
were used. In order to investigate the inﬂuence of hormone intake
on SoS variations during the menstrual cycle, the differences
between the follicular and luteal phase were ﬁrst calculated and a
student t test was performed between the hormone and non-
hormone groups. For the three frequently measured women,
repeated measures ANOVA was used to assess differences in SoS
and DSoS within the investigated period.
3. Results
511 out of 520 (98.27%) segment measurements were successful.
Four of the unsuccessful measurements were due to poor gel
coupling and ﬁve due to false distance readings by the examiner.
These errors were easily identiﬁed since the ultrasound echoes did
then not appear within the SoS reading interval (Fig. 1). The
comfort score was in the range 1 to 2 (Table 1).
Figure 1. Speed-of-Sound (SoS) ultrasound (US) examination setting. (A) View from ventral: breast with positioning frame, reﬂector, US probe and distance
adjustment unit; (B) right breast viewed from above showing the three measured breast segments; (C) Annotation of average SoS value (1562m/s) and SoS
variation range (‘breast heterogeneity’) DSoS=12m/s in a dense breast segment. The back wall echo of the reﬂector is used as a timing reference. The automatic
reading is displayed as an overlaid red line.
Ruby et al. Medicine (2019) 98:25 www.md-journal.com
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3.1. Average measurements of both breasts
3.1.1. Comparison of the follicular and luteal phase. For SoS,
both unpaired t test (P= .786) and paired t test (P= .126) did not
indicate a signiﬁcant difference (Fig. 2a). Themean SoS difference
between follicular and luteal phases was 3.2m/s with a standard
deviation (SD) of 9.2m/s (Fig. 3a). For DSoS, both unpaired
(P= .470) and paired (P= .257; 95%-CI -1.58; 5.58) t test did not
indicate a signiﬁcant difference in between follicular and luteal
phases (Fig. 2b). The mean DSoS difference between follicular
and luteal acquisitions was 2.0m/s, with SD=7.7m/s (Fig. 3b).
From the current sample size (n=20), we can conclude that in a
95% conﬁdence interval the mean variation is [1.1; 7.5m/s] for
SoS and [1.6; 5.6m/s] for DSoS. We found an ICC of 0.985
(P< .001) for SoS and 0.757 (P< .01) for DSoS.
3.1.2. Frequently measured women. One-way repeated mea-
sures ANOVA indicated ANOVA indicated no signiﬁcant change
in SoS over the seven measured time points (P= .892) (Fig. 4).
3.1.3. Hormone vs non-hormone. Considering the differences
between the follicular and luteal phase in the twenty women, the
comparison of the hormone and non-hormone group was not
signiﬁcant for either SoS (P= .614) or DSoS (P= .735).
3.1.4. Inter-examiner agreement. Comparing the two exam-
iners, we found a correlation of rs=0.959 (P< .001) and an ICC
of 0.990 for SoS (Fig. 5), and a correlation of rs=0.612 (P< .01)
and an ICC of 0.811 for DSoS (Fig. 5). For SoS, the average
Figure 2. Boxplots of SoS (A) and DSoS (B) values of the follicular (n=20) and
luteal phases (n=20). Average measurements of both breasts are plotted. The
P values represent a comparison using paired t test. Figure 3. Correlation of SoS (A) and DSoS (B) measurements of the follicular
(n=20) and luteal phases (n=20) (average measurements of both breasts).
Figure 4. Frequently measured women. Average values of six segments (three
per breast) over a 25-day period.
Ruby et al. Medicine (2019) 98:25 Medicine
4
difference between the examiners was2.2m/s, with SD = 7.6m/
s. ForDSoS, the average difference was 1.4m/s, with SD=6.4m/s.
3.1.5. Inter-reader agreement. Comparing the two readers, we
found a correlation coefﬁcient of rs=0.997 (P< .001) for SoS and
rs=0.870 (P< .001) for DSoS. The ICC was 0.999 for SoS and
0.922 forDSoS. Themean SoS difference between the readers was
2.1m/s, with SD=1.86m/s. The mean DSoS difference was 4.0
m/s, with SD=4.7m/s. Comparing the mean of both manual
readers with the automatic reading, we found a correlation
coefﬁcient of rs=0.992 and an ICC=1.000 for SoS and rs=0.925
and an ICC=0.957 forDSoS. Figure 6 displays the comparison of
the automatic reading and the mean of both manual readers
(“manual annotation”).
3.1.6. Comparison of variances. The variance between
measurements in follicular/luteal phases was not signiﬁcantly
different from the variance between measurements performed by
two examiners on the same day (P= .461 for SoS and P= .477 for
DSoS). For SoS, the variance between measurements performed
by the same examiner and annotated by two different manual
readers was signiﬁcantly smaller than the variance between
measurements performed by two examiners and annotated by the
same manual reader (P< .001), while for DSoS the difference of
SD was not signiﬁcant (P= .173) (Fig. 7). The variance between
the automatic and manual readers was not signiﬁcantly different
than the variance between two different manual readers for either
SoS (P= .694) and DSoS (P= .318). The variance between
measurements in follicular/luteal phases was signiﬁcantly larger
than the variance between measurements performed by the same
examiner and annotated by two different manual readers for SoS
(P< .001) and for DSoS (P= .035).
4. Discussion
We showed that the SoS variability was not signiﬁcantly different
over the menstrual cycle and comparable to the inter-examiner
variability. Measurements of different examiners and manual
readers showed a high reproducibility.
Evidence of menstrual cycle-related histological changes of the
breast gland tissue has been published.[24] According to
According to Bertrand et al., who investigated the role of sex
steroid hormones by menstrual timing and mammographic
density in premenopausal women, follicular estradiol and sex
hormone-binding globulin may play an important role in
premenopausal percent mammographic density.[25] For imaging
modalities, different results with respect to the variation of breast
density during themenstrual cycle have been published:Magnetic
resonance imaging studies demonstrated an increased parenchy-
mal volume during the luteal phase, cycle-dependent changes in
contrast enhancement, as well as an overall ﬂuctuation in breast
density of about 7%.[26–28] However, Hovhannisyan et al and
Buist et al showed non-signiﬁcant changes in mammographic
breast density, whereas White et al found small, but signiﬁcant
changes over the menstrual cycle.[29–31] According to Miglioretti
et al, the accuracy of mammographic density measurements is
affected by the timing during the menstrual cycle.[32] Using
multimodal ultrasound tomography, which combines SoS with
other biomarkers, such as acoustic attenuation, Forte et al did not
observe statistically signiﬁcant changes over the menstrual
cycle.[33] Our results indicate that variations of breast density
within the menstrual cycle, if at all present, are small (SoS
variation 95% CI [1.1,7.5] m/s equivalent to breast density
variations between [1.1,7.5]%). We found that there is no
statistically signiﬁcant difference in SoS and DSoS between the
follicular and luteal phase among volunteers with very dense
breasts. Unpaired analysis shows that the density differences
among volunteers with extremely dense breasts are larger than
the variations of density within one volunteer within the
menstrual cycle. Paired analysis and F-test indicate that the
random SoS variance between follicular and luteal cycles for the
same volunteer (SD=9.2m/s) is not signiﬁcantly larger than the
observed inter-examiner variance on the same day (SD=7.6m/s).
Whereas Dorgan et al found breast density to be inversely
associated with the age women began taking hormonal contra-
ceptives and positively correlated with the duration of hormone
use, Haars et al did not observe an inﬂuence of oral contraceptive
intake on breast density.[34,35] The comparison of the increments
between the follicular and luteal phase did not reveal a signiﬁcant
difference between the hormone intake and non-hormone intake
groups.
In our measurements, the inter-reader error appears smaller
than the inter-examiner variability for both manual and
automatic readings. Moreover, reproducibility errors due to
mechanical inaccuracy of the reﬂector positioning system are
Figure 5. Correlation of SoS (A) and DSoS (B) measurements between
examiner 1 and examiner 2 (average measurements of both breasts).
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considered negligible from previous calibration measurements in
reference materials.[13] Therefore, we interpret that the main
reproducibility constraint is related to accessing exactly the same
breast plane twice with the ultrasound probe. In contrast to this,
ultrasound computed tomography (USCT) systems measure the
full breast volume. However, the average of the three segments
provides a stable predictor of overall breast density. Variations
on different measurement days are not signiﬁcantly larger than
the inter-examiner variability on the same day. Therefore,
unaccounted menstruation variations do not seem to have a
signiﬁcant confounder impact on SoS measurement reproduc-
ibility. Measuring the same patients twice with different USCT
devices on the same day, Sak et al[36] found a repeatability of
SD=6.3m/s, ICC=0.973, rs=0.808. Measuring a population
characterized by dense breasts, we found similar interexaminer
variations (SD=7.6m/s; ICC=0.990; rs=0.959). Khodr et al
measured the reproducibility of SoS USCT for breast density
assessment with a follow-up scan one to thirteen months after
the ﬁrst scan per person with the same system.[37] They found a
SoS change with a SD of 5.74m/s with an ICC of 0.933.
In comparison, we found an ICC of 0.985 with a SD of 9.2m/s
for SoS and an ICC of 0.757 (P< .01) with a SD of 7.7m/s for
DSoS.
There are some limitations to our study. Our sample size was
small and we only measured over a single menstruation cycle. A
further limitation is that we performedmeasurements only at two
time points for the larger group (N=20). In addition, conclusions
regarding breast density could be affected by the high breast
density of the women studied, that is, changes throughout the
menstrual cycle may be smaller in dense breasts. The acquisition
of only three planes as compared to the entire breast volume using
USCT, which could be interpreted as a limitation, has been shown
to provide a stable predictor of overall breast density.
While SoS-US showed high reproducibility in comparison with
state-of-the-art USCT systems, the alterations during the
menstrual cycles were smaller than the conﬁdence interval of
measurements. In conclusion, the SoS variability was not
signiﬁcant throughout the menstrual cycle and similar to the
Figure 6. Bland-Altman plot. Automatic annotation – manual annotation (mean of reader 1 and reader 2).
Ruby et al. Medicine (2019) 98:25 Medicine
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inter-examiner variability. Measurements between examiners
and readers showed a high reproducibility.
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